Your Physician Knowledge Center
Everything clinicians need to evaluate, adopt, and order HelioLiver LDT — the epigenomic blood test for earlier detection of hepatocellular carcinoma. Available for clinical use today through Quest Diagnostics.
Clinical Resources for Physicians
Browse the scientific evidence, study details, technology, and ordering information behind HelioLiver LDT — built for hepatologists, gastroenterologists, oncologists, and the teams who care for high-risk patients.
Provider Overview
Why HelioLiver belongs in your HCC surveillance protocol — the epigenomic blood test for high-risk patients.
OpenClinical Evidence
Performance metrics, sensitivity and specificity data, and the full body of evidence behind HelioLiver.
OpenCLiMB Study
The pivotal, prospective, blinded, multicenter US trial — design, cohort, and key outcomes.
Open Coming soonPublications
Peer-reviewed publications across Nature, PNAS, Nature Communications, and the Journal of Hepatology.
Coming soonPhysician Case Studies
Real-world clinical pathways showing HelioLiver in practice, presented in a HIPAA-compliant format.
Coming soonParticipating Hospitals & Trial Sites
Academic centres, cancer centres, and clinical networks involved in HelioLiver research.
Patent & Technology
The proprietary ECLIPSE™ epigenomic platform and the patented methylation science behind it.
OpenFrequently Asked Questions
Answers to the most common clinical questions about HelioLiver LDT, testing, and results.
OpenContact Medical Affairs
Reach our Medical Affairs and MSL team for scientific questions, data requests, and onboarding.
OpenBuilt on Nearly a Decade of Peer-Reviewed Science
Hepatology